Thyroid Cancer Archive
Multiple studies at ENDO 2017 highlighted the dangers linked to both environmental toxin and common household chemical exposure.
Patients with government subsidized or self-pay insurance were less likely to undergo thyroidectomy for thyroid cancer.
Increases in papillary thyroid cancer were most common between 1974 and 2013.
Elemental calcium — found in cow's milk — significantly limits a person's ability to absorb oral levothyroxine.
Younger survivors of thyroid cancer are at increased risk for certain types of health problems later in life.
For patients with unresected anaplastic thyroid carcinoma, overall survival is poor, but radiation therapy dose is associated with improved survival.
Widespread routine thyroid cancer screening can lead to overdiagnosis and overtreatment, according to the statement.
Does core-needle biopsy perform better than repeat fine-needle aspiration for evaluating thyroid nodules?
CDC27 mutations may be associated with less aggressive behavior while SLC25A5 mutations may be associated with more aggressive behavior in papillary thyroid carcinomas.
The first-in-class compound CUDC-907, which is being tested for multiple myeloma and refractory lymphoma, may be promising for anaplastic thyroid cancer and poorly differentiated thyroid cancer.
Long-term recurrence rates appear to be low following the use of recombinant human thyrotropin for postoperative ablation in low-risk thyroid cancer.
Initiating treatment with the mTor inhibitor everolimus followed by the somatostatin analogue pasireotide may be beneficial in advanced thyroid cancer.
A new study has validated the American Thyroid Association sonographic pattern for selection of thyroid nodules undergoing ultrasound-guided fine needle aspiration.
Active surveillance in low-risk thyroid cancer may be better than immediate surgery in some patients.
Despite side effects, patients with differentiated thyroid cancer taking lenvatinib may experience better outcomes with close monitoring.
Liquid biopsy may prevent the need for unnecessary biopsies in patients with medullary thyroid carcinoma.
Researchers have identified estimates for risk of occult nodal disease of patients with papillary thyroid cancer who have undergone surgery.
More imaging tests after treatment does not always lead to an improvement in thyroid cancer patients' chances of survival.
There were no effective therapeutic options for advanced thyroid cancer until 5 years ago.
The recent increase may be caused by an 'epidemic of diagnosis,' not harmful tumors, researchers said.
Local-regional failure in well-differentiated thyroid cancer mostly occurs outside of 70 Gy volume and in peri-esophageal region.
The risk for complications was 87% higher when a surgeon's case load is1 thyroidectomy case a year.
However, nearly one-third of patients develop lifelong complications following thyroid surgery.
The likelihood of developing breast or thyroid cancer as a secondary malignancy is increased following diagnosis of the other cancer.
Physicians using gene expression classifier testing said that in 86% of cases, identifying a benign result through testing and potentially avoiding surgery improved patient safety.
Second primary malignancies among patients with post-Chernobyl papillary thyroid cancer include hematological malignancies, breast carcinoma, cervical carcinoma, and colon carcinomas.
Patients with thyroid cancer report worse quality of life than others diagnosed with more lethal cancers.
Genetic alterations were found in both cancerous and benign samples.
Results in this expanded series reaffirm the data in the pilot study and show a 5-year overall survival rate of 43%.
Patients with medullary thyroid cancer taking cabonzantinib lived more than 2 years longer if their tumors had a RET mutation.
New results show no significant associations between dietary habits and thyroid cancer risk.
Rates lower for surgeons performing 25 or more total thyroidectomies a year.
Excellent accuracy for 10-year disease-specific death, recurrence.
Positive link to papillary, follicular, anaplastic thyroid cancer; inverse link for medullary thyroid cancer.
Many cases involve low-risk tumors where treatments could carry greater risks than benefits.
Recombinant human TSH avoids transient health-related quality-of-life deterioration seen with thyroid hormone withdrawal.
Cervical lymph node metastases are associated with compromised survival in young patients with papillary thyroid cancer.
Acupuncture may be an effective treatment for patients with thyroid cancer who experience radioactive-iodine-induced (RAI)-induced anorexia.
HABP2 G534E variant is a susceptibility gene for familial nonmedullary thyroid cancer and functions as a dominant-negative tumor-suppressor gene.
New developments in molecular profiling have been included in an updated position statement on thyroid cancer.
Timing of radioactive iodine ablation doesn't affect overall survival in papillary thyroid cancer.
Sonographic pattern should be used to determine the threshold for thyroid nodule biopsy and can stratify the risk for malignancy.
Obese women who undergo thyroidectomy may require a higher dose of levothyroxine than nonobese women.
New sonographic patterns proposed in the provisional 2014 ATA guidelines perform well for medullary thyroid cancer.
The American Thyroid Association has released the first guidelines for evaluating and managing thyroid nodules and thyroid cancer in pediatric patients.
The risk for thyroid cancer appears to be increased in breast cancer survivors, especially among younger patients with invasive ductal carcinoma.
A trained scent dog was able to accurately identify thyroid cancer in urine samples from patients with thyroid nodules.
Sunitinib appears to exhibit significant antitumor activity in patients with advanced differentiated thyroid cancer.
After 5 years, less than 1% of asymptomatic nodules studied were diagnosed as thyroid cancer.
Drug approved to treat progressive, differentiated thyroid cancer that is refractory to radioactive iodine therapy.
Lenvatinib improved progression-free survival and response rate in I-131-refractory thyroid cancer.
Radioactive iodine therapy was associated with improved survival and reduced mortality risk.
Radiation effects on thyroid nodules were noted in people who survived the atomic bombings at Hiroshima and Nagasaki.
Maximum tumor size may predict outcomes after treatment with sorafenib in radioactive iodine-refractory differentiated thyroid cancer.
A next-generation sequencing panel of genetic markers may improve cancer diagnosis of indeterminate thyroid nodules.
Sex hormones may account for the differences between men and women in the development of follicular thyroid cancer.
A blood assay that measures BRAF mutation levels may be helpful in diagnosing and monitoring papillary thyroid cancer.
Only moderate suppression of thyroid-stimulating hormone improves outcomes in all stages of differentiated thyroid cancer.
Radioactive iodine therapy may slightly improve survival in papillary thyroid carcinoma.
Combining Lithium With Radioactive Iodine Therapy for Metastatic Radioiodine-Refractory Thyroid Cancer
Combining lithium with radioactive iodine therapy may improve survival in patients with metastatic radioiodine-refractory thyroid cancer.
Radioactive iodine therapy with low-activity I-131 may result in worse survival and more radiation exposure in patients with differentiated thyroid cancer.
The incidence of renal cancer and thyroid cancer is increasing among children and adolescents in the United States.
Thyroid nodular disease and thyroid cancer prevalence appears to be higher in patients with acromegaly.
Long-term follow-up is important in children with thyroid cancer to prevent late recurrence.
Lenvatinib, a new TKI inhibitor, delays disease progression and shows promising clinical efficacy against differentiated radioiodine-resistant thyroid cancer.
Endocrinology Advisor Articles
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Dulaglutide Effective for Patients With T2D, Moderate to Severe CKD
- Incidence of Diabetes Influenced by Endocrine-Disrupting Chemicals in the Environment
- Guidelines for Management of Hypothalamic-Pituitary, Growth Disorders in Childhood Cancer Survivors
- Assessment of Low-Dose Aspirin As Chemoprevention in Type 2 Diabetes
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Adjunctive Metformin for Insulin Resistance in T1D: A Clinical Perspective
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Type 2 Diabetes and Alzheimer Disease: What's the Connection?
- Government and Industry Lead the Way in Funding USPSTF Systematic Reviews
- New Romosozumab BLA Includes Data from Additional Osteoporosis Trials
- Impact of Maternal Diabetes on Outcomes in Very Preterm, Very Low-Birth-Weight Infants
- Age-Related Differences in Manifestation of Cushing Disease Identified